Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls
Information source: University Hospital, Basel, Switzerland
Information obtained from ClinicalTrials.gov on November 03, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Glaucoma
Phase: N/A
Status: Recruiting
Sponsored by: University Hospital, Basel, Switzerland Official(s) and/or principal investigator(s): Selim Orgül, MD, Study Director, Affiliation: University Eye Clinic Basel
Overall contact: Matthias C Grieshaber, MD, Phone: +41 61 265 8781, Email: mgrieshaber@uhbs.ch
Summary
Retinal structures are difficult to visualize because the retina is optically transparent. In
glaucoma, the microglia in the retina becomes activated in eyes with glaucomatous damage. The
microglia forms a dense meshwork which resembles gliosis-like alterations, which may increase
light scattering. With appropriate technology, increased reflection and light scattering from
the retina may be detected in eyes of glaucoma patients.
In this study, we investigate whether clinically observable retinal gliosis-like alterations
occur more often in patients with glaucoma than in non-glaucomatous controls, and whether
gliosis-like alterations are associated with a vasospastic propensity.
Clinical Details
Official title: Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls
Study design: Case-Only, Prospective
Detailed description:
Glaucoma is an optic neuropathy characterized by a progressive loss of retinal ganglion cells
and cupping of the optic nerve head associated with visual function defects. Increased
intraocular pressure and vascular alterations such as unsteady blood flow have been
implicated in the pathogenesis of glaucoma. While glaucoma changes occur in both the retina
and the optic nerve head, clinical diagnosis normally focuses on optic nerve head. However,
histomorphologic and immunohistochemistry studies have shown that glial cells in the retina
(astrocytes and Müller cells) are also activated in glaucoma. In addition, some patients with
glaucoma have clinically patchy alteration in the retina resembling epiretinal gliosis but
without visual disturbance, thus the term "gliosis-like alterations" was used previously. At
present however, it is unknown whether gliosis-like alterations are associated with a
specific type of glaucoma (i. e. high- or normal-tension glaucoma) or with vascular
dysregulation. Moreover, it remains unclear whether gliosis-like alterations may also occur
in the elderly patients without glaucoma as an aging process of the retina. Retinal
structures are difficult to visualize and details difficult to be imaged on a photograph
because the retina is optically transparent. Blue light scatters more than red light. This is
the reason why the retinal nerve fiber layer can to some extent be better visualized with
red-free light. The extensions of the astrocytes in the retina form a fine meshwork, which
becomes denser and irregular as these astrocytes are activated. The size and numbers of glial
cells increase, as the neural cell damage advances. These changes, in turn, may increase the
light scattering. With appropriate technology, increased reflection and light scattering from
the retina may be detected in the retina of glaucoma patients. The purpose of the study is to
evaluate whether gliosis-like alterations do occur more often in glaucoma.
The retina of patients and healthy controls alike will be photographically documented with a
digital fundus camera as well as with optical coherence tomography and automated
microperimetry that enables to correlate objectively local morphologic aspects and changes of
the retina with local functional measurements. Possible causes for secondary retinal gliosis
will be excluded in a thorough clinical examination including slit-lamp examination and
dilated direct fundoscopy. The examination techniques and interventions used in this study
are routine clinical practice and do not expose patients or controls to undue risk.
Eligibility
Minimum age: 45 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
For NTG patients :
- untreated intraocular pressure equal to or less than 21mmHg or
- median intraocular pressure equal to or less than 20mmHg
For HTG patients:
- mean untreated intraocular pressure more than 21mmHg
For both:
- open drainage angles on gonioscopy
- typical optic disc damage with glaucomatous cupping and thinning of neuroretinal rim
- absence of any secondary cause for a glaucomatous optic neuropathy
- visual field defects congruent to glaucomatous disc damage (disc/field correlation)
Healthy subjects:
- no history of ocular diseases
- no current topical medication
- no drug or alcohol abuse
- best corrected visual acuity above 20/25 in both eyes
- no pathological findings upon a slit-lamp examination and fundoscopy
- IOP < 21 mmHg in both eyes
Exclusion Criteria:
For NTG and HTG patients:
- any other form of retinal or neuroophthalmologic disease that could cause gliosis-like
retinal alterations or result in visual field defects
- history of chronic or recurrent severe inflammatory eye disease
- history of ocular trauma or intraocular surgery
- history of infection or inflammation within the past 3 months
- history and clinical evidence for other retinal disease
Locations and Contacts
Matthias C Grieshaber, MD, Phone: +41 61 265 8781, Email: mgrieshaber@uhbs.ch
University Eye Clinic, Basel 4031, Switzerland; Recruiting Selim Orgul, MD, Email: sorguel@uhbs.ch
Additional Information
Starting date: January 2006
Ending date: December 2008
Last updated: September 25, 2008
|